Risks and Benefits of Urinary Catheter in Elective Cesarean Section
NCT ID: NCT03459963
Last Updated: 2018-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
170 participants
INTERVENTIONAL
2017-05-18
2018-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Catheterization During Second Elective Caesarean Delivery
NCT02143089
Filling of the Urinary Bladder During Difficult Cesarean Section
NCT03668535
Caesarean Delivery With or Without an Indwelling Bladder Catheter. A Randomised Trial.
NCT03479931
Comparison of Immediate Versus Delayed Removal of Urinary Catheter Following Elective Cesarean Section
NCT02074852
IUD Insertion During Cesarean Section
NCT03492034
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study population will be randomized using computer sequence program in 1:1 ratio. Allocation of every patient to one of the studied groups will be done using opaque envelops.
The studied groups will be either Group C or Group N For both groups
* A written consent will be taken.
* Full history to exclude medical problems that need special care.
* Full history to exclude UTI or recurrent UTI during pregnancy.
* A single dose of 2 gm cefazolin will be given IV pre-incision for preoperative antibiotic prophylaxis (Sullivan et al., 2007).
* midstream urine samples will be collected preoperative to exclude UTI and 24 hours postoperatively after giving the instructions to the patients (washing hands and genitals ,pass some urine into the toilet then without stopping catch some urine in a sterile container ) to be analyzed for presence of UTI
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group C
indwelling urinary catheter
indwelling urinary catheter
85 women undergoing first elective CS will be catheterized immediately preoperatively using Foley's catheter by applying catheterization precautions.
group N
Non cathetrized patients
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
indwelling urinary catheter
85 women undergoing first elective CS will be catheterized immediately preoperatively using Foley's catheter by applying catheterization precautions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* haemodynamically stable
Exclusion Criteria
* presence of Medical complications that requiring special care e.g: diabetes with pregnancy, hypertensive disorders with pregnancy, cardiac disease, chronic renal disease,
* previous cesarean section
* Previous abdominal surgery which may be associated with extensive adhesions, -polyhydraminos
* fetal macrosomia
* significant vaginal bleeding
* Contraindication for the antibiotic used e.g: anaphylaxis
* Need for extensive use of antibiotics more than the prophylactic dose
* Spinal anesthesia.
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
World Health Organization
OTHER
Ain Shams Maternity Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dina Islam
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tamer F borg
Role: PRINCIPAL_INVESTIGATOR
Ain Shams Maternity Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University Maternity Hospital.
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
elgammal
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.